Published in Transplant Proc on March 01, 1969
Evolution of liver transplantation. Hepatology (1982) 19.54
New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Detection of circulating immune complexes in pathological human sera. Lancet (1975) 2.51
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Calcium metabolism following renal transplantation. Ann Clin Biochem (1994) 2.03
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
The fate of serially transplanted bone marrow cell populations from young and old donors. Transplantation (1976) 1.98
Renal function in 29 healthy adults before and after nephrectomy. JAMA (1966) 1.96
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Fungus infections after liver transplantation. Ann Surg (1977) 1.81
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
The quality of life after liver transplantation. Transplant Proc (1979) 1.78
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol (1975) 1.77
Prognostic factors in sterile pancreatic necrosis. Gastroenterology (1992) 1.77
Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Competitive in vivo proliferation of foetal and adult haematopoietic cells in lethally irradiated mice. J Cell Physiol (1972) 1.70
Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology (1994) 1.70
Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest (1968) 1.69
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation. Br Med J (1971) 1.58
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54
Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr (1990) 1.53
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Liver replacement for pediatric patients. Pediatrics (1979) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ (1992) 1.50
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Magnetic resonance angiography of renal artery stenosis. Clin Radiol (1995) 1.41
Decline in survival after liver transplantation. Arch Surg (1980) 1.39
Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int (1989) 1.39
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Coccidioidomycosis in renal replacement therapy. Arch Intern Med (1982) 1.36
Pathology of liver transplantation. Transplant Rev (1969) 1.36
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33
Virus-induced obstruction of the ureteric and cystic duct in allograft recipients. Transplant Proc (1973) 1.33
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30
Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis. Trans Am Soc Artif Intern Organs (1966) 1.27
Liver transplantation of Budd-Chiari syndrome. JAMA (1976) 1.26
Donor and recipient function 2 to 4 years after renal homotransplantation. A paired study of 28 cases. Ann Intern Med (1967) 1.24
Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients. Arch Dis Child (1972) 1.20
A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16
Significance of haematuria in hypertensive patients. Lancet (1980) 1.16
Measurement of glomerular permeability to polydisperse radioactively-labelled macromolecules in normal rabbits. Clin Sci (1968) 1.16
Repopulation of Peyer's patches in mice. Nature (1967) 1.14
Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14
Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology (1991) 1.13